Strengthening Partnerships Between Fertility Clinics and Research Centres
Strengthening Partnerships Between Fertility Clinics and Research Centres
Ground-breaking advances in reproductive medicine rely on strong partnerships between scientists, clinicians, health professionals and patients. Recent evidence suggests a disconnect between many patients’ wishes and the opportunities available to them: around half of patients would like the option to donate their surplus embryos to research (National Patient Survey)1, but only a minority of clinics currently offer this pathway. As a result, many embryos that could contribute to scientific discovery are ultimately discarded.
around half of patients would like the option to donate their surplus embryos to research
As the reproductive science community looks to the future, an important question emerges: how can we better support patient choice while advancing research that has the potential to improve fertility treatments and reproductive health? The Human Fertilisation and Embryology Authority (HFEA) recently proposed that regulation should be amended to allow patients to donate to a research bank to store embryos, whether or not their clinic is currently linked to any research projects itself (Modernising fertility law)2. The research embryo bank could then allocate the stored embryos to suitable research projects when needed, in line with the patients’ consent. If adopted, this process could simplify the donation process, increase patient access to research donation pathways, and provide valuable resources for scientific investigation.
While these discussions continue, there are already opportunities to strengthen collaboration across the sector, accelerate innovation, and improve outcomes for patients. Here, we highlight our research at the Babraham Institute in Cambridge, which aims to foster closer connections between fertility clinics and research centres. By bringing together expertise in fertility care, embryology, stem cell biology, and developmental research, these partnerships translate cutting-edge scientific discoveries into insights that ultimately benefit patients and families.
Engineering a womb lining model to witness embryo implantation and the hallmarks of post-implantation development
Our research aims to understand how embryonic and extraembryonic cell lineages are established during early human embryo development. This critical period encompasses implantation of the embryo into the womb lining (endometrium) and the establishment of interactions between the embryo and the endometrium that are necessary for a successful pregnancy. Failures occurring during this developmental window contribute to unsuccessful implantation and to reduced success rate of fertility treatment, while abnormal implantation and placental development are associated with complications that can develop later in pregnancy, such as pre-eclampsia and growth restriction.
Our research aims to understand how embryonic and extraembryonic cell lineages are established during early human embryo development
Despite its essential role in pregnancy establishment, how the human embryo undergoes implantation remains poorly understood, in part due to a lack of experimental systems that faithfully replicate the maternal environment required to support early post-implantation development. By studying embryos that have been donated to our research programme by consented patients, and working under HFEA licencing, we have investigated processes through which early embryonic development is controlled and how they shape interactions between the embryo and the maternal environment during implantation.
Our recent publication3, Modeling Human Embryo Implantation In Vitro, describes a new system that recapitulates the receptive endometrium. To build this model, we combine an endometrial stromal compartment with a layer of epithelial cells on the surface. This system recreates key features of the receptive endometrial environment including formation of endometrial glands and appropriate responses to oestrogen and progesterone stimulation. Embryos attach to and progressively invade the endometrial cells, allowing visualisation of these events in real time. Once implanted, the embryos continue to develop, hitting key developmental milestones, until the experimental endpoint at day 14. They form remarkable organisation of the epiblast and early placental lineage as it invades the endometrium, which are crucial events that have not been seen before in an experimental model (Image 1 and Image 2).
Image 1
Microscopy image of a day 14 human embryo that has implanted in the new endometrial model. The bright blue cells in the centre of the image are unspecialised epiblast cells that later in development form all of the tissues of the body. The orange-coloured cells are trophoblast cells that will later form the placenta. The blue cells surrounding the embryo are endometrial cells that support embryo implantation and growth. Credit: image taken by Matteo Molè at the Babraham Institute.
Image 2
Left: Microscopy image of a human embryo at 14 days post-fertilisation following implantation within the endometrial model. The orange cells correspond to the epiblast, the cell population that gives rise to all tissues of the developing foetus. The pink cells represent the hypoblast, which contributes to formation of the yolk sac, as well as the amniotic cavity. Right: Higher-magnification view of the region outlined in the left panel, highlighting the organisation of the epiblast and the developing amniotic cavity at 14 days post-fertilisation. Image credit: Matteo Molè, at the Babraham Institute.
To understand how embryonic and endometrial cells communicate during these stages, we profiled patterns of gene activity in single cells within the implantation niche. This revealed a complex network of cell-cell interactions at the embryo-endometrial interface. We tested whether one of these pathways is important by applying a specific inhibitor that blocks this line of communication between cells. Excitingly, this changed the behaviour of the early placental cells within the endometrial model by preventing their ability to successfully invade. These results provide evidence that reciprocal signalling between embryonic and endometrial cells are necessary to the control implantation and early placental development.
this research represents a significant advance in our ability to study human embryo implantation and growth
By establishing a new model of receptive endometrium, this research represents a significant advance in our ability to study human embryo implantation and growth, providing access to an important yet poorly understood stage of our development. Beyond enabling detailed study of embryo-endometrial interactions, this platform creates new opportunities to investigate the cellular and molecular determinants of implantation success and early pregnancy establishment. As experimental and analytical technologies continue to advance, there is increasing scope to strengthen multidisciplinary collaborations between researchers and clinicians, ensuring that fundamental discoveries can be translated into clinically relevant insights and ultimately contribute to improving reproductive health outcomes for patients.
Looking to the Future
Our laboratory is keen to partner with treatment centres that would like to engage with scientific research and innovation, and to use this knowledge to ultimately improve outcomes for patients. Building strong networks between researchers, clinicians, embryologists, and other reproductive health professionals will create opportunities for collaborative projects, knowledge exchange, and future discoveries.
If you are interested in learning more about our research or in forming a collaboration, please visit https://www.babraham.ac.uk/our-research/epigenetics/peter-rugg-gunn/human-embryo-research or contact us at peter.rugg-gunn@babraham.ac.uk
References
1. https://www.hfea.gov.uk/about-us/publications/research-and-data/national-patient-survey-2024/
2. https://www.hfea.gov.uk/about-us/modernising-the-regulation-of-fertility-treatment-and-research-involving-human-embryos/modernising-fertility-law/#summary-of-recommendations
3. Molè, Elderkin, Zorzan, Penfold, Horsley et al., Cell 2006 doi.org/10.1016/j.cell.2025.10.027